Occupational trichloroethylene exposure and antinuclear antibodies: a cross-sectional study in China.
Autoimmune Diseases
Cross-Sectional Studies
Epidemiology
Solvents
Journal
Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
02
02
2022
accepted:
16
04
2022
pubmed:
4
5
2022
medline:
17
9
2022
entrez:
3
5
2022
Statut:
ppublish
Résumé
There has been concern over the possible risk of autoimmune diseases from exposure to trichloroethylene (TCE), an industrial solvent and common pollutant near hazardous waste sites. Studies of TCE-exposed lupus-prone mouse strains have reported increases in serum antinuclear antibodies (ANAs), a marker of autoimmunity, and autoimmune pathologic changes, while epidemiologic studies have provided limited support for an association between TCE exposure and scleroderma. To investigate exposure-related biologic evidence of autoimmunity in humans, we measured ANA levels in sera from a cross-sectional study of TCE-exposed (n=80) and TCE-unexposed (n=96) workers in Guangdong, China. Full-shift personal air exposure measurements for TCE were taken prior to blood collection. Serum ANAs were detected by immunofluorescence on HEp-2 cells. We calculated ORs and 95% CI relating levels of TCE exposure (categorised using tertiles as cut-points) and ANA positivity (1+ intensity at 1:320 dilution) using multivariable logistic regression. Samples from 16 of 176 participants were ANA-positive. We found higher levels of TCE exposure (concentrations>17.27 ppm) to be associated with an elevated odds of ANA positivity (OR 4.7, 95% CI 1.3 to 16.8) compared with unexposed controls. This association remained after excluding two subjects with diagnosed autoimmune disease (OR 4.5, 95% CI 1.2 to 16.2). We did not observe an association with ANAs at lower exposure levels. Our findings, to our knowledge the first direct human evidence of an association between TCE exposure and systemic autoimmunity, provide biologic plausibility to epidemiologic evidence relating TCE and autoimmune disease.
Identifiants
pubmed: 35504721
pii: oemed-2022-108266
doi: 10.1136/oemed-2022-108266
pmc: PMC10187559
mid: NIHMS1802033
doi:
Substances chimiques
Antibodies, Antinuclear
0
Biological Products
0
Trichloroethylene
290YE8AR51
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
717-720Subventions
Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Occup Environ Med. 2002 Aug;59(8):545-9
pubmed: 12151611
Arthritis Rheum. 2012 Jul;64(7):2319-27
pubmed: 22237992
Environ Health Perspect. 2009 May;117(5):696-702
pubmed: 19479009
Autoimmun Rev. 2003 May;2(3):119-25
pubmed: 12848952
Arthritis Rheum. 1998 Jun;41(6):1111-8
pubmed: 9627022
Carcinogenesis. 2010 Sep;31(9):1592-6
pubmed: 20530238
Mod Rheumatol. 2009;19(3):219-28
pubmed: 19277826
Curr Ther Res Clin Exp. 2014 Nov 26;76:116-9
pubmed: 25473438
Arthritis Rheumatol. 2020 Jun;72(6):1026-1035
pubmed: 32266792
N Engl J Med. 2003 Oct 16;349(16):1526-33
pubmed: 14561795
Am J Epidemiol. 2003 Mar 15;157(6):493-500
pubmed: 12631538
Arthritis Rheumatol. 2016 Oct;68(10):2492-502
pubmed: 27059145
Reumatol Clin. 2017 May - Jun;13(3):150-155
pubmed: 27221374
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462